Prenuvo, a Redwood City, CA-based provider of a radiation-free whole body imaging for early detection of cancer and other diseases, raised $70m in Series A funding.
The round was led by Felicis, with participation from existing investors including Tony Fadell, Dr. Timothy A. Springer, Anne Wojcicki, Steel Perlot, Rande Gerber, and Cindy Crawford.
The company intends to use the funds to invest in its artificial intelligence (AI) team, new radiology tools, custom advanced MRI builds, and national expansion.
Led by CEO Andrew Lacy and Dr. Raj Attariwala, Prenuvo offers MRI using AI to proactively screen for cancer and disease in under one hour. A single scan covers 26 regions and organs of the body in under 60 minutes. With high clinical diagnostic quality, it can screen for and diagnose more than 500 conditions – including most solid tumors at Stage 1.
The company operates preventative screening clinics in Vancouver, Silicon Valley, Los Angeles, Dallas, Boca Raton, and Minneapolis, and plans to launch additional locations over the next year, in cities including New York City, Chicago, Boston, and Bethesda.
FinSMEs
18/10/2022